Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NS5A inhibitors(Nonstructural protein 5A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC42H50N8O7 |
InChIKeyQKFUCROVTLGTAV-VOIOCNMVSA-N |
CAS Registry1246470-32-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Preclinical | US | 14 Oct 2013 | |
Hepatitis C | Preclinical | CN | 14 Oct 2013 |